Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Dimitrov

Showing results (361-370 of 442) with videos related to

Pageof 45
Sort By:
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|December 7, 2007
Surveillance of antibacterial resistance in Staphylococcus aureus isolated in Kuwaiti hospitalsE E Udo, N Al-Sweih, R Dhar, et al.
Biochemical and Biophysical Research Communications|August 26, 2006
Polo-like kinase 1-mediated phosphorylation of the GTP-binding protein Ran is important for bipolar spindle formationYang Feng, Jin Hui Yuan, Sharon C Maloid, et al.
Antiviral Research|April 9, 2017
Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosetsNeeltje van Doremalen, Darryl Falzarano, Tianlei Ying, et al.
Journal of Immunological Methods|November 3, 2006
Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panningMei-Yun Zhang, Vidita Choudhry, Igor A Sidorov, et al.
Journal of Virology|December 17, 2013
Structural basis for HIV-1 neutralization by 2F5-like antibodies m66 and m66.6Gilad Ofek, Brett Zirkle, Yongping Yang, et al.
AIDS (London, England)|May 16, 2018
A defucosylated bispecific multivalent molecule exhibits broad HIV-1-neutralizing activity and enhanced antibody-dependent cellular cytotoxicity against reactivated HIV-1 latently infected cellsDesheng Kong, Yan Wang, Ping Ji, et al.
NPJ Vaccines|February 9, 2021
A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virusThomas W Geisbert, Kathryn Bobb, Viktoriya Borisevich, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 14, 2023
Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cellsNayanendu Saha, Du-San Baek, Rachelle P Mendoza, et al.
Journal of Immunological Methods|December 9, 2003
Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display libraryMei-Yun Zhang, Yuuei Shu, Sanjay Phogat, et al.
Immunology and Cell Biology|March 8, 2005
Marked structural and functional heterogeneity in CXCR4: separation of HIV-1 and SDF-1alpha responsesAndrew J Sloane, Vic Raso, Dimiter S Dimitrov, et al.
Pageof 45

Showing results (361-370 of 442) with videos related to

Sort By:
Pageof 45
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|December 7, 2007
Surveillance of antibacterial resistance in Staphylococcus aureus isolated in Kuwaiti hospitalsE E Udo, N Al-Sweih, R Dhar, et al.
Biochemical and Biophysical Research Communications|August 26, 2006
Polo-like kinase 1-mediated phosphorylation of the GTP-binding protein Ran is important for bipolar spindle formationYang Feng, Jin Hui Yuan, Sharon C Maloid, et al.
Antiviral Research|April 9, 2017
Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosetsNeeltje van Doremalen, Darryl Falzarano, Tianlei Ying, et al.
Journal of Immunological Methods|November 3, 2006
Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panningMei-Yun Zhang, Vidita Choudhry, Igor A Sidorov, et al.
Journal of Virology|December 17, 2013
Structural basis for HIV-1 neutralization by 2F5-like antibodies m66 and m66.6Gilad Ofek, Brett Zirkle, Yongping Yang, et al.
AIDS (London, England)|May 16, 2018
A defucosylated bispecific multivalent molecule exhibits broad HIV-1-neutralizing activity and enhanced antibody-dependent cellular cytotoxicity against reactivated HIV-1 latently infected cellsDesheng Kong, Yan Wang, Ping Ji, et al.
NPJ Vaccines|February 9, 2021
A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virusThomas W Geisbert, Kathryn Bobb, Viktoriya Borisevich, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 14, 2023
Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cellsNayanendu Saha, Du-San Baek, Rachelle P Mendoza, et al.
Journal of Immunological Methods|December 9, 2003
Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display libraryMei-Yun Zhang, Yuuei Shu, Sanjay Phogat, et al.
Immunology and Cell Biology|March 8, 2005
Marked structural and functional heterogeneity in CXCR4: separation of HIV-1 and SDF-1alpha responsesAndrew J Sloane, Vic Raso, Dimiter S Dimitrov, et al.
Pageof 45